Location History:
- New York City, NY (US) (2020)
- Hoboken, NJ (US) (2023)
Company Filing History:
2 out of 950 
2 out of 168 
Years Active: 2020-2023
Title: The Innovative Contributions of Ya-Chi Chen
Introduction
Ya-Chi Chen is a prominent inventor based in New York, NY (US). She has made significant strides in the field of cancer therapy, particularly through her innovative work on GPC3-targeting drugs. With a total of 2 patents, her contributions are paving the way for advancements in cancer treatment.
Latest Patents
Ya-Chi Chen's latest patents focus on methods for determining the efficacy of GPC3-targeting drug therapy for cancer patients. One patent describes a method for assessing the effectiveness of this therapy before its initiation or during its course. This involves analyzing the number of immunocytes or the expression level of specific molecules in biological samples from patients. The second patent outlines a similar approach, emphasizing the monitoring of free GPC3 concentrations in biological samples to determine the therapy's efficacy. Both patents aim to enhance patient outcomes by providing tailored treatment options based on individual responses to GPC3-targeting drugs.
Career Highlights
Throughout her career, Ya-Chi Chen has worked with notable companies in the pharmaceutical industry, including Chugai Seiyaku Kabushiki Kaisha and F. Hoffmann-La Roche AG. Her experience in these organizations has contributed to her expertise in drug development and cancer therapies.
Collaborations
Ya-Chi Chen has collaborated with esteemed colleagues such as Toshihiko Ohtomo and Jun Amano. These partnerships have further enriched her research and innovation in the field of cancer treatment.
Conclusion
Ya-Chi Chen's work exemplifies the impact of innovative thinking in the medical field. Her patents and collaborations highlight her commitment to improving cancer therapies, ultimately benefiting patients worldwide.